KYAN Technologies

Leader in functional precision medicine for oncology

KYAN Technologies is headquartered in Singapore, Singapore and lists 11–50 employees.

Headquarters
Singapore
Employees
11–50
Business Model
B2B

About

KYAN Technologies is a Singapore-based biotechnology company pioneering functional precision medicine for oncology. The company's flagship platform, Optim.AI™, combines small data artificial intelligence with live biological experiments to analyze the functional response of drug-dose combinations on a patient's own tumor cells. Founded by scientific co-founders from UCLA and National University of Singapore, KYAN identifies optimal multi-drug combinations for individual cancer patients across more than 20 tumor types, with an average clinical accuracy exceeding 80%. The company serves both clinicians seeking personalized treatment guidance and biopharma organizations accelerating drug development. KYAN's laboratory in Singapore is licensed by the Ministry of Health (MOH) and accredited by the College of American Pathologists (CAP).

Summary

KYAN Technologies is an Artificial Intelligence company based in Singapore, Singapore. It lists 11–50 employees.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

KYAN Technologies on Indexed.vc
<a href="https://indexed.vc/companies/kyan-technologies"><img src="https://indexed.vc/api/badge/company/kyan-technologies" alt="KYAN Technologies on Indexed.vc" width="260" height="76" /></a>